Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia
Puedes acceder al artículo completo en este enlace: https://erj.ersjournals.com/content/59/3/2103036#abstract-2
Noticias relacionadas
Plasticity of Individual Lung Function States from Childhood to Adulthood
Recent evidence highlights the importance of optimal lung development during childhood for health throughout life. Objectives: To explore the plasticity of individual lung function states during childhood.
Inhaled corticosteroids for the treatment of COVID-19
Evidence from clinical studies indicates that the inhaled corticosteroids (ICS) routinely taken for asthma and COPD could have had a protective role in preventing severe COVID-19 and, therefore, may be a promising treatment for COVID-19.
Más artículos
COVID19
- ·Cruz, T., et al., SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae. ERJ Open Research, 2022. 8(1): p. 00706-2021
- Mona Bafadhel, Rosa Faner, Camille Taillé, Richard E.K. Russell, Tobias Welte, Peter J. Barnes and Alvar Agustí. Inhaled corticosteroids for the treatment of COVID-19
- Bartolome Celli et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision
- Alvar Agustí, Esther Pallisa, Domingo Escudero, Manel Escobar. Propuestas JANUS para la mejora de la experiencia de la persona atendida en consultas externas
- Alvar Agustí, Bernardino Alcázar, Julio Ancochea, Ciro Casanova, Bartolome Celli, Borja Cosio, José María Echave-Sustaeta, Alberto Fernandez Villar, Juan Luis Garcia Rivero, Cruz González, José Luis Iz. ANTES: Un año después en la EPOC
Recuerda que puedes acceder a varios enlaces a artículos en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imágenes obtenidas el 29/12/2022 de la aplicación Canva Pro.
